Current Studies
Inhalt
Printout - Studies
Current portfolio of clinical trials
Prostate Cancer
Urothelial Carcinoma of the Bladder
Renal Cell Carcinoma
Studies planned, Recruitment not yet open
Prostate Cancer
- new hormonal therapy for high risk biochemical recurrence
- Antibody drug conjugate for mCRPC
Renal Cell Carcinoma
- TKI + TIGIT Antibody + PD-L1 antibody for ccRCC
Urothelial Carcinoma of the Bladder
-
slow release Gemcitabine for BCG naive urothelial carcinoma